Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Journal of Crohn'S & Colitis|August 19, 2014
How can we improve models of care in inflammatory bowel disease? An international survey of IBD health professionalsAntonina Mikocka-Walus, Jane M Andrews, David Rampton, et al.Digestive Diseases (Basel, Switzerland)|March 6, 2010
Does stress influence inflammatory bowel disease? The clinical dataDavid RamptonDigestive Diseases (Basel, Switzerland)|June 28, 2014
Are maintenance strategies underused in Crohn's disease?David RamptonPolskie Archiwum Medycyny Wewnetrznej|April 30, 2015
Treatment of iron deficiency anemia: practical considerationsSophia Taylor, David RamptonInflammatory Bowel Diseases|January 14, 2012
Integrated models of care in managing inflammatory bowel disease: a discussionAntonina A Mikocka-Walus, Jane M Andrews, Charles N Bernstein, et al.BMJ Case Reports|May 23, 2014
The dangers of living in a tent in LondonRichard Frederick De Butts, Anna Li, James Goodhand, et al.Journal of Crohn'S & Colitis|December 21, 2025
Clinical utility of pre-treatment 4-digit resolution HLA genotyping to guide anti-TNF choice and concomitant immunomodulator usePhoebe Hodges, Christopher Roberts, Miles Parkes, et al.Journal of Crohn'S & Colitis|September 19, 2025
Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, and therapeutic potentialMichael Colwill, Sebastian Povlsen, Richard Pollok, et al.Journal of Crohn'S & Colitis|September 27, 2012
Yield and cost effectiveness of mycobacterial infection detection using a simple IGRA-based protocol in UK subjects with inflammatory bowel disease suitable for anti-TNFα therapyKay Greveson, James Goodhand, Santino Capocci, et al.Haematologica|November 25, 2014
Hypersensitivity reactions to intravenous iron: guidance for risk minimization and managementDavid Rampton, Joergen Folkersen, Steven Fishbane, et al.Pageof 2